How and which interventions should be prioritized for human clinical trials?

Establish prioritization criteria and identify specific ageing-targeting interventions to advance into human clinical trials, balancing efficacy, safety, and feasibility.

Background

Selecting interventions for human testing is a critical translational challenge. The authors include this among underrepresented open problems.

Developing robust prioritization frameworks will accelerate clinical geroscience and resource allocation.